Plain-English translation of NCT03870230 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Glaucoma damages the nerve cells in your eye, often because of high eye pressure. Doctors can slow this damage by lowering eye pressure, but some patients still lose vision despite good pressure control. This study is investigating whether problems with blood flow in the retina—the light-sensitive tissue at the back of the eye—might be part of the problem. Researchers will use special imaging to measure how your retina's blood vessels respond to flickering light in both glaucoma patients and healthy people.
Most glaucoma treatments focus only on lowering eye pressure, but this doesn't help all patients. Scientists believe that better blood flow to nerve cells in the eye might protect them from damage independently of pressure—a strategy called neuroprotection. This study is exploring whether abnormal blood flow patterns in glaucoma could be a new treatment target.
You likely qualify if…
You likely don't qualify if…
You will visit the research center for testing where doctors will perform detailed eye imaging and measurements while your eye is exposed to flickering light. This helps researchers see how your retina's blood vessels respond to visual stimulation. The study compares results across different groups: people with different types of glaucoma at different stages, people with high eye pressure alone, and healthy volunteers. The exact number and timing of visits will be explained to you during enrollment.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Austria